Vanguard Group’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.22M	Buy	409,100 +153,700	+60%	+$456K	﹤0.01%	3691
2025 Q1	$582K	Buy	255,400 +30,400	+14%	+$69.3K	﹤0.01%	3848
2024 Q4	$857K	Buy	+225,000	New	+$857K	﹤0.01%	3811